查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584738

動物用藥品原料藥市場：按業務、按適應症、按合成、按類型、按最終用戶 - 2025-2030 年全球預測

Animal Health Active Pharmaceutical Ingredients Market by Business, Indication, Synthesis, Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物用藥品原料藥市場價值為174.1億美元，預計2024年將達到188.2億美元，複合年成長率為8.23%，到2030年將達到302.8億美元。

動物用藥品原料藥（API）市場包括用於製造改善動物健康和生產力的動物用藥品的生物活性物質配方。對 API 的需求源於控制通用感染疾病、改善牲畜健康以確保優質食品生產以及加強伴同性動物護理的日益成長的需求。其用途廣泛，包括抗生素、抗寄生蟲藥、發炎藥物、疫苗、營養食品等，適用於獸醫院、診所、農場等多種最終用途。影響該市場的主要成長要素包括寵物擁有量的增加、動物疾病發病率的上升以及對食品安全和永續農業實踐的日益重視。有機肉類產品需求的激增也推動了市場成長，為天然環保原料藥的開發創造了潛在機會。市場主要參與者能夠透過基於生物技術的 API 配方的創新和藥物輸送系統的進步來利用這一趨勢。

主要市場統計
基準年[2023] 174.1億美元
預測年份 [2024] 188.2億美元
預測年份 [2030] 302.8億美元
複合年成長率（%） 8.23%

影響市場成長的挑戰包括嚴格的法律規範、原料藥開發的高成本以及抗生素抗藥性的出現。此外，供應鏈中斷和原物料價格波動也是主要障礙。然而，研發方面的策略性投資可以透過實現更有效率的生產流程和新穎的治療解決方案來緩解這些挑戰。創新成熟的領域包括獸醫應用的精準醫學以及人工智慧在原料藥發現中的應用，這可能會顯著提高活性藥物成分的功效和可用性。

該市場呈現出動態特徵，將數位健康工具整合到獸醫醫學中的趨勢日益明顯，例如遠端醫療和健康監測設備。為了有效地抓住這些機會，相關人員必須建立策略夥伴關係，利用技術進步，並根據不斷變化的消費者偏好和監管標準保持永續的做法。建立強大的供應鏈並投資針對特定市場的療法可以進一步增強市場定位和長期成長。

市場動態：揭示快速發展的動物用藥品原料藥市場的關鍵市場洞察

動物用藥品市場正因供需的動態交互作用原料藥轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球寵物擁有率不斷上升
    • 提高大眾對動物保健的認知和支出
    • 動物保健非政府組織顯著增加
  • 市場限制因素
    • 與動物用藥品相關的一些危險因子
  • 市場機會
    • 大眾對動物健康的認知不斷增強
    • 提高動物生產力
  • 市場挑戰
    • 認知有限且原料成本波動

波特五力：駕馭動物用藥品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解動物用藥品原料藥市場的外部影響

外部宏觀環境因素在塑造動物用藥品原料藥市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解動物用藥品原料藥競爭狀況

對動物用藥品原料藥市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV動物用藥品原料藥市場定位矩陣供應商績效評估

FPNV定位矩陣是評估動物用藥品原料藥市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪動物用藥品原料藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對動物用藥品原料藥市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地寵物擁有量呈上升趨勢
      • 提高大眾對動物保健的認知和支出
      • 動物保健非政府組織數量顯著成長
    • 抑制因素
      • 與動物用藥品相關的一些危險因子
    • 機會
      • 提高大眾對動物健康的認知
      • 提高動物生產力
    • 任務
      • 缺乏認知和原料成本波動
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物用藥品原料藥市場：依業務分類

  • 專屬式的活性藥物成分
  • 商業活性藥物成分

第7章動物用藥品原料藥市場適應症

  • 抗感染
  • 驅蟲藥
  • 非類固醇消炎劑和麻醉劑

第8章動物用藥品原料藥綜合市場

  • 生物技術
  • 合成

第9章動物用藥品原料藥市場：依類型

  • 品牌
  • 非專利的

第10章動物用藥品原料藥市場：依最終用戶分類

  • 寵物護理醫院
  • 零售/專業藥房

原料藥章：美洲動物用藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太動物用藥品原料藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲動物用藥品原料藥

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Changzhou Yabang-Qh Pharmachem Co., Ltd.
  • Eli Lilly & Co.
  • Excel Industries Limited
  • Glenmark Pharmaceutical Ltd.
  • Heska Corporation
  • HIKAL Ltd.
  • Indukern, SA
  • Lonza Group AG
  • NGL Fine Chem Ltd.
  • Ofichem BV
  • Orion Corporation
  • Sequent Scientific Ltd.
  • Suanfarma, SA
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zoetis Inc.
Product Code: MRR-430D3EB72270

The Animal Health Active Pharmaceutical Ingredients Market was valued at USD 17.41 billion in 2023, expected to reach USD 18.82 billion in 2024, and is projected to grow at a CAGR of 8.23%, to USD 30.28 billion by 2030.

The Animal Health Active Pharmaceutical Ingredients (APIs) market encompasses the formulation of biologically active substances used in the manufacture of veterinary medicines that improve animal health and productivity. The necessity for APIs arises from the growing need to manage zoonotic diseases, improve livestock health to ensure quality food production, and enhance companion animal care. Applications span across antibiotics, anti-parasitic and anti-inflammatory drugs, vaccines, and nutritional supplements, serving various end-use segments such as veterinary hospitals, clinics, and farms. Key growth factors influencing this market include increasing pet ownership, rising incidences of animal diseases, and a growing emphasis on food safety and sustainable farming practices. The surge in demand for organic meat products also propels market growth, creating potential opportunities in the development of natural and eco-friendly APIs. Market players can capitalize on this trend by innovating in biotechnology-based API formulations and advancing in drug delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 17.41 billion
Estimated Year [2024] USD 18.82 billion
Forecast Year [2030] USD 30.28 billion
CAGR (%) 8.23%

Challenges affecting market growth include stringent regulatory frameworks, high costs of API development, and the advent of antibiotic resistance. Moreover, supply chain disruptions and fluctuating raw material prices pose significant hurdles. Nevertheless, strategic investments in R&D can mitigate these challenges by enabling more efficient production processes and novel therapeutic solutions. Areas ripe for innovation include precision medicine tailored for veterinary applications and the utilization of AI in drug discovery, which can lead to breakthroughs in API effectiveness and accessibility.

The market exhibits a dynamic nature with a growing inclination towards integrating digital health tools in animal care, such as telemedicine and health monitoring devices, thereby opening new vistas for API applications. To effectively capture these opportunities, stakeholders need to form strategic partnerships, leverage technological advancements, and maintain sustainable practices that align with evolving consumer preferences and regulatory standards. Establishing robust supply chains and investing in market-specific therapies can further enhance market positioning and long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Health Active Pharmaceutical Ingredients Market

The Animal Health Active Pharmaceutical Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption of pets across the globe
    • Increasing awareness and expenditure among people regarding the animal healthcare
    • Significant growth in the number of animal healthcare NGOs
  • Market Restraints
    • Several risk factors associated with animal health APIs
  • Market Opportunities
    • Growing awareness amongst people regarding animal health
    • Improvements in the animal productivity
  • Market Challenges
    • Limited awareness and variations in raw material cost

Porter's Five Forces: A Strategic Tool for Navigating the Animal Health Active Pharmaceutical Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Health Active Pharmaceutical Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Health Active Pharmaceutical Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Health Active Pharmaceutical Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Health Active Pharmaceutical Ingredients Market

A detailed market share analysis in the Animal Health Active Pharmaceutical Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Health Active Pharmaceutical Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Health Active Pharmaceutical Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Health Active Pharmaceutical Ingredients Market

A strategic analysis of the Animal Health Active Pharmaceutical Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Health Active Pharmaceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Limited, Glenmark Pharmaceutical Ltd., Heska Corporation, HIKAL Ltd., Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ofichem BV, Orion Corporation, Sequent Scientific Ltd., Suanfarma, SA, Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Health Active Pharmaceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Business, market is studied across Captive Active Pharmaceutical Ingredient and Merchant Active Pharmaceutical Ingredient.
  • Based on Indication, market is studied across Anti-Infectives, Antiparasitics, and Non-Steroidal Anti-Inflammatory Drugs & Anesthetics.
  • Based on Synthesis, market is studied across Biotech and Synthetic.
  • Based on Type, market is studied across Branded and Generic.
  • Based on End User, market is studied across Pet Care Hospitals and Retail & Specialty Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of pets across the globe
      • 5.1.1.2. Increasing awareness and expenditure among people regarding the animal healthcare
      • 5.1.1.3. Significant growth in the number of animal healthcare NGOs
    • 5.1.2. Restraints
      • 5.1.2.1. Several risk factors associated with animal health APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing awareness amongst people regarding animal health
      • 5.1.3.2. Improvements in the animal productivity
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and variations in raw material cost
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Health Active Pharmaceutical Ingredients Market, by Business

  • 6.1. Introduction
  • 6.2. Captive Active Pharmaceutical Ingredient
  • 6.3. Merchant Active Pharmaceutical Ingredient

7. Animal Health Active Pharmaceutical Ingredients Market, by Indication

  • 7.1. Introduction
  • 7.2. Anti-Infectives
  • 7.3. Antiparasitics
  • 7.4. Non-Steroidal Anti-Inflammatory Drugs & Anesthetics

8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis

  • 8.1. Introduction
  • 8.2. Biotech
  • 8.3. Synthetic

9. Animal Health Active Pharmaceutical Ingredients Market, by Type

  • 9.1. Introduction
  • 9.2. Branded
  • 9.3. Generic

10. Animal Health Active Pharmaceutical Ingredients Market, by End User

  • 10.1. Introduction
  • 10.2. Pet Care Hospitals
  • 10.3. Retail & Specialty Pharmacies

11. Americas Animal Health Active Pharmaceutical Ingredients Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Animal Health Active Pharmaceutical Ingredients Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Animal Health Active Pharmaceutical Ingredients Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Changzhou Yabang-Qh Pharmachem Co., Ltd.
  • 2. Eli Lilly & Co.
  • 3. Excel Industries Limited
  • 4. Glenmark Pharmaceutical Ltd.
  • 5. Heska Corporation
  • 6. HIKAL Ltd.
  • 7. Indukern, S.A.
  • 8. Lonza Group AG
  • 9. NGL Fine Chem Ltd.
  • 10. Ofichem BV
  • 11. Orion Corporation
  • 12. Sequent Scientific Ltd.
  • 13. Suanfarma, SA
  • 14. Zhejiang Hisun Pharmaceutical Co. Ltd
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS & ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL & SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023